The pioneering research led by academics from the Sheffield Institute of Translational Neuroscience (SITraN), in collaboration with scientists from the University of York, supports the fast - tracking of
the drug ursodeoxycholic acid (UDCA) for a clinical trial in Parkinson's patients.